Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1067 | 1044 | 1155 | 1248 | 1598 | 2913 |
Fund Return | 6.72% | 4.4% | 15.5% | 7.66% | 9.83% | 11.29% |
Place in category | 4035 | 3750 | 4144 | 2036 | 1440 | 448 |
% in Category | 59 | 55 | 67 | 41 | 38 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux C JPY | 13.36B | 4.59 | 2.37 | - | ||
Cap Group NewPerspective lux ZL JPY | 13.94B | 4.37 | 1.78 | 10.00 | ||
Capital Group Global Allocation Fcj | 1.33B | 4.49 | 4.89 | 8.21 | ||
EM Total Opportunities LUX Cj | 594.69M | 0.23 | -1.28 | 2.84 | ||
Cap Group inv CoAmerica lux Z JPY | 421.53M | 6.53 | 8.49 | 10.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Research Equity t | 55.55B | 15.42 | 15.19 | 14.57 | ||
MS Global Brands Fund Aj | 21.41B | -0.57 | 2.17 | 8.36 | ||
MFS Global Value ex Japan Fund Q4JP | 96.65M | 13.23 | 18.00 | 12.40 | ||
ValueInvest LUX Global A Disj | 457.32M | 3.70 | 4.07 | 7.77 | ||
ValueInvest LUX Global I Caj | 457.32M | 4.04 | 5.07 | 8.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.23 | 927.3 | +1.13% | |
Broadcom | US11135F1012 | 2.79 | 1,328.55 | -2.45% | |
Microsoft | US5949181045 | 2.33 | 415.13 | +0.23% | |
Safran | FR0000073272 | 2.07 | 214.10 | +0.14% | |
AstraZeneca | GB0009895292 | 2.05 | 12,190.0 | +1.35% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review